Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL ...

Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...

BostonGene collaborates with BeiGene to advance biomarker discovery in mantle cell lymphoma: Waltham, Massachusetts Thursday, February 13, 2025, 09:00 Hrs [IST] BostonGene, a lead ...

Patients treated in community settings were more likely to be older, less likely to be White, and had worse survival rates, ...

This marks the first time a Bruton tyrosine kinase (BTK) inhibitor has been approved for the 1st-line treatment of MCL in the United States. The decision followed a Priority Review of findings ...

Feb. 5. 2025 – The FDA has approved a new pill to treat adults with a type of blood cancer called mantle cell lymphoma (MCL). This treatment is for people who are newly diagnosed or haven't h ...

He then adds that for older individuals, treatment may involve isometric knee exercises without the need for ACL reconstruction. “The MCL, located on the outside of the knee joint, can suffer ...

and MCL treatment guidelines could reshape management strategies, with consideration given to factors such as efficacy, safety, and patient access.

Any players closest coming back at all? Conor Chaplin is still not going to be available. Sam Smoddick, thankfully, the ankle ...

This marks the first time a Bruton tyrosine kinase (BTK) inhibitor has been approved for the 1st-line treatment of MCL in the United States. The decision followed a Priority Review of findings from ...

Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...